UK markets close in 14 minutes

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.90-0.56 (-5.86%)
As of 11:16AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2020
Cash flows from operating activities
Net income
-151,085
-151,085
-216,207
-10,663
Depreciation & amortisation
810
810
131
0
Deferred income taxes
-26,529
-26,529
-2,857
-
Stock-based compensation
29,392
29,392
24,965
336
Change in working capital
-18,858
-18,858
-2,831
-489
Accounts payable
-2,722
-2,722
6,351
-49
Other working capital
-160,511
-160,511
-201,683
-10,630
Other non-cash items
28
28
173
-
Net cash provided by operating activities
-160,342
-160,342
-200,546
-10,630
Cash flows from investing activities
Investments in property, plant and equipment
-169
-169
-1,137
-
Purchases of investments
-264,910
-264,910
0
-
Sales/maturities of investments
138,075
138,075
0
-
Other investing activities
-
-
206
-
Net cash used for investing activities
-127,004
-127,004
-931
0
Cash flows from financing activities
Debt repayment
-
-
-
0
Common stock issued
20,807
20,807
0
0
Common stock repurchased
-
-
-
0
Other financing activities
-
-
-261
1
Net cash used provided by (used for) financing activities
21,117
21,117
457
1,362
Net change in cash
-265,614
-265,614
-201,438
-9,343
Cash at beginning of period
393,644
393,644
595,082
16,570
Cash at end of period
128,030
128,030
393,644
7,227
Free cash flow
Operating cash flow
-160,342
-160,342
-200,546
-10,630
Capital expenditure
-169
-169
-1,137
-
Free cash flow
-160,511
-160,511
-201,683
-10,630